Small-Molecule Antiviral β- <scp>d</scp> - <i>N</i> <sup>4</sup> -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
Maria L. Agostini(VIR Biotechnology (United States)), Mark R. Denison(Bipar), Jennifer Gribble(Vanderbilt University), Ralph S. Baric(University of North Carolina at Chapel Hill), George R. Painter(Emory University), Xiaotao Lu(Vanderbilt University Medical Center), Amy Sims(Georgia State University), Gregory R. Bluemling(Emory University), Alexander A. Kolykhalov(Emory University), Manohar Saindane(Emory University), Michael G. Natchus(Emory University), James D. Chappell(King Saud bin Abdulaziz University for Health Sciences), Erica L. Andres(Vanderbilt University Medical Center), Timothy P. Sheahan(University of North Carolina at Chapel Hill), Mark A. Lockwood(Emory University), Andrea J. Pruijssers(Vanderbilt Health)
Cited by 355
Related Papers
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking
|Nature Biotechnology|2016|4.7k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
|New England Journal of Medicine|2015|1.9k
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k